How Australia's Leading CRO Is Driving Biotech's Acceleration From First-In-Human To Global Markets

Despite launching his career in the financial public relations industry in Chicago, an invitation from a friend led Mark Harvill to join the clinical mission of STRATPROBE in Ann Arbor, Michigan. The rest is history. Harvill dedicated himself to learning everything he could about the science and operations behind the CRO industry, and now, three decades later, he has taken the helm as CEO at Australia’s leading CRO, Avance Clinical.

Harvill’s appointment at Avance Clinical is a reflection of his experience and leadership values, which closely align with the CRO’s. He recognizes the importance of serving early-stage innovators and biotechs, a practice that Avance has long been committed to. Plus, Harvill believes that the key to clinical success is prioritizing relationships with your clients and meeting key milestones.

Download the full article to learn more about Mark Harvill, Avance Clinical, and what to expect in their next era.